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Previous studies in animals and humans have implicated the X-
chromosome STS gene in the etiology of attentional difﬁculties
andattentiondeﬁcithyperactivitydisorder(ADHD).Thisfamily
basedassociationstudyhasﬁnemappedaregionoftheSTSgene
across intron 1 and 2 previously associated with ADHD, in an
extended sample of 450 ADHD probands and their parents.
Signiﬁcant association across this region is demonstrated indi-
vidually with 7 of the 12 genotyped SNPs, as well as an allele
speciﬁchaplotypeofthe12SNPs.Theovertransmittedriskallele
of rs12861247 was also associated with reduced STS mRNA
expression in normal human post-mortem frontal cortex brain
tissue compared to the non-risk allele (P¼0.01). These results
are consistent with the hypothesis arising from previous litera-
turedemonstratingthatboyswithdeletionsoftheSTSgene,and
hence no STS protein are at a signiﬁcantly increased risk of
developing ADHD. Furthermore, this study has established the
brain tissue transcript of STS, which except from adipose tissue,
differs from that seen in all other tissues investigated.




Attention deﬁcit hyperactivity disorder (ADHD) is one of the
most heritable and prevalent childhood psychiatric disorders
[Asherson, 2004], affecting an estimated 5% of school-aged chil-
dren [Polanczyk et al., 2007]. Like most other neurobehavioral
disorders, ADHD presents with a male bias [Swanson et al., 1998],
which supports a possible role for X-linked genes in the etiology.
Recent work from both human and animal studies suggests the
X-linked gene; steroid sulfatase (STS) may have a role in attention.
Boys with X-linked ichthyosis, who have a deletion or point
mutation of STS are at an increased risk of ADHD [Kent et al.,
2008] and common variants within the STS gene may increase
susceptibilitytoADHD[Brookesetal.,2008].Bothpharmacologi-
cal manipulation of the steroid sulfatase axis and haplo-insufﬁ-
ciency of the STS gene have been shown to affect components
of attentional functioning in mice [Davies et al., 2007, 2009]. STS,
whichescapesXinactivationinhumans,desulfatesseveral sulfated
steroids including sulfated dehydroepiandrosterone, known as
DHEA-S to DHEA. Both are neurosteroids with effects on several
neurophysiological and behavioral processes including some evi-
dence for an inverse relationship between DHEA blood levels and
clinical symptomatology in boys with ADHD [Strous et al., 2001].
Additionally, methylphenidate, the commonest treatment for
ADHD, has been shown to produce signiﬁcant clinical improve-
ment in boys with ADHD and simultaneous increases in serum
levels of DHEA-S and DHEA, suggesting that these neurosteroids
may play a role in the therapeutic effects of methylphenidate
[Maayan et al., 2003].
We previously genotyped tagging SNPs (which capture the
majority of diversity of genetic variation across a region) across
theSTSgene,withanevidenceofassociationaroundintron1and2
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Neuropsychiatric Genetics[Brookes et al., 2008]. This follow-up study, in an extended
association sample has attempted to narrow down this region of
association by genotyping more SNPs across intron 1 and 2. STS is
known to have at least nine alternate ﬁrst exons, with at least eight
tissue speciﬁc transcripts [Dalla Valle et al., 2007; Zaichuk et al.,
2007;Nardietal.,2009],althoughbraintissuehasnotyetbeenfully
investigated. We have investigated cDNA from human post-mor-
tem brain tissue to establish the brain tissue transcript for STS
and have investigated possible functional roles of associated SNPs
through investigation of STS mRNA levels.
MATERIALS AND METHODS
In this study, 450 probands and their parents were genotyped for
12 ﬁne mapping STS SNPs. Eight of these SNPs had not been
genotypedinourpreviousstudyof383probandswhilefourofthese
SNPs(rs5934740,rs7058445,rs2270112,andrs12861247)hadbeen
previously genotyped in 383 of the 450 probands [Brookes et al.,
2008].ThereforethedataforeightSNPsinall450probandsisnovel,
and the data for the four previously genotyped SNPs is new for the
additional 67 probands only.
Association Sample
For this study 450 ADHD probands (inclusive of 12 affected
siblings) and their parents were recruited from several child
psychiatry clinics in the UK (N¼183) and Ireland (N¼267),
following approval from the appropriate research ethics commit-
tees. Parental DNA was available for 98% of mothers and 68% of
fathers. After complete description of the study to the subjects,
written informed consent was obtained. For 380 of the probands
from the UK and Ireland, parents were interviewed by trained
psychiatrists or psychologists employing the Child and Adolescent
Psychiatric Assessment (CAPA) [Angold et al., 1995]. Consistent
interview procedures were employed across the two centers with
researchers from each center receiving a common training in the
use of the CAPA. Inter-rater reliability kappa coefﬁcients were
calculated for ADHD subtype diagnoses (k¼0.82; CI¼0.71–0.94).
The remaining 70 UK probands were interviewed with the parent
versionoftheK-SADSinterview[Kaufmanetal.,1997]byatrained
psychologist. Consistent interview procedures were employed
across the two centers with researchers from each center receiving
a common training in the use of the CAPA. Inter-rater reliability
kappa coefﬁcients were calculated for ADHD subtype diagnoses
(k¼0.82; CI¼0.71–0.94). In addition, teacher ratings were ob-
tained for children by the Conners Teacher Rating Scale (CTRS)
[Conners, 1998]. This was to conﬁrm that symptoms met the
criterion of pervasiveness. Established cut-off points for possible
andlikelyADHDcasenessontheCTRSwereadheredto,thatis,aT-
score above 55 which was required. All 450 probands were White
and born in the UK or Ireland (Age range 4–16 years). The sample
was predominantly male (90.1%) with no signiﬁcant difference in
sex ratio between the two study recruitment centers. All probands
fulﬁlled DSM-IV diagnostic criteria for ADHD. Of these N¼42
(9.3%) had the inattentive subtype, and N¼38 (8.4%) had the
hyperactive impulsive subtype, the rest had combined subtype
(82.3%). Children with an IQ below 70, autistic spectrum disorder
or signiﬁcant medical conditions such as epilepsy were excluded.
Two-hundredelevenchildren(46.9%)hadcomorbidoppositional
deﬁant disorder and 69 children (15.3%) fulﬁlled criteria for
comorbid conduct disorder. Frequencies of subtype and comor-
bidity were similar across the two recruitment centers.
Human Post-Mortem Brain Sample
Twenty-one (all male) samples of human post-mortem frontal
cortex were obtained from the Medical Research Council (MRC)
Sudden Death Brain and Tissue Bank, Edinburgh prior to this
study. Deceased individuals were aged 16–70 years (mean¼
46.3 years). RNA quality was measured by optical density (OD)
with a Bioanalyzer (Agilent, CA). Sample OD260/OD280 ratios
ranged from 1.5 to 2.0. Mean brain pH was 6.3 (SD¼0.25). The
sampleswerecrushedandstoredat 80 Cforfutureuse.RNAand
DNA extraction was carried out using the MELT  Total Nucleic
AcidIsolationSystem(AppliedBiosystem ,FosterCity,CA,1983)
andconcentrationsdeterminedusingaNanoVue(GEHealthCare,
UK). The cDNA was created with reverse transcriptase-mediated
polymerase chain reaction (RT-PCR) using the AfﬁnityScript 
QPCR cDNA Synthesis Kit (Stratagene, CA) on the Mx3005P
machine (Stratagene).
Association Study and Brain sample Genotyping
For association study samples, high molecular weight genomic
DNAwasextractedfromwholeblood,cheekswaborOragenesaliva
collection systems (DNA Genotek, Ontario, Canada) according to
routine procedures. Brain issue DNA was extracted as above.
Fine mapping SNPs for STS were selected from Hapmap based on
heterozygosityandlinkagedisequilibriumparametersandrs1473666
in exon 0b was identiﬁed asdescribed below. SNP genotyping assays
were obtained from Applied Biosystems for use on the Stratagene
Mx3005Preal-timePCRmachine(Stratagene)followingstandard-
ized protocols provided with the assays.
Alternative First Exon Genotyping
The sequences of the recently documented six alternate ﬁrst exons
ofSTSdesignated0a,0b,0c,1a(exon1a,216basepairsinsize,isthe
previouslyknownexon1ofSTS),1b,1c,and1dbyDallaValleetal.
[2007], were compared to the human genome sequence using
BLAST (http://blast.ncbi.nlm.nih.gov) to determine genomic
location. Figure 4 demonstrates their relative positions. Exons 0a
(351bp) and 0b (77bp) are in the 50 region of the upstream gene,
5HDHD1A, which is transcribed from the reverse strand, exon
0c (341bp) is intragenic between 5HDHD1A and STS, exon 1b
(129bp) is in the 50 region of STS and exons 1c (98bp) and 1d
(246bp)arewithinintron1oftheSTSgene.TwoSNPsfromdbSNP
were identiﬁed, currently labeled as intronic, but which lie in these
alternateﬁrstexons:bothrs12839420andrs1473666resideinexon
0b but only rs1473666 was polymorphic.
Ampliﬁcation of cDNA to establish the presence/absence of
alternative ﬁrst exons in the STS human brain transcript was
performed on 21male and 7 female post-mortem brain samples.
Primer pair ampliﬁcations were combined into two multiplex and
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primer set for detecting cDNA in the known coding region of the
STS gene, and a negative control pair set which detected intronic
DNA(seeSupplementaryTableI).GenomicDNAwasampliﬁedin
eachreaction asapositivecontrolforthepresenceofallalternative
exons. cDNA samples were run in triplicate. Standard PCR con-





from 150 (for exon 2) and 100 (for exons 0a and 1b) male ADHD
probands and 96 male controls obtained from Human Random
Control DNA panels (HRC-1 and -2; European Collection of Cell
Cultures, Sigma–Aldrich, Salisbury, UK). For exon 0a a product
of 556bp was obtained using primers (50GCAGCTGTTCTCAAA-
CGTTCACGC30) and (50GGCTCCGCGTCCTCTCCTCA30); for
exon 1b a product of 617bp was obtained with primers
(50GGGTTGGGAACCCCTG CTGC30) and (50ACATGGTCT-
GGGTGAGTCAAACACT30); for exon 2 a product of 713bp was
obtained using primers located within intron 1 (50AGGCTGTT-
GACCCCATACAC30) and intron 2 (50GTGTCATGAAGGCAGG-
TGTG30) and ampliﬁed using standard conditions and thermal
cycles. Sequence was compared to genomic DNA NCBI ref
sequence (NC_000023.10) using CodonCode Aligner version 3
(CodonCode Corporation) to identify novel polymorphisms.
cDNA PCR products from eight male human brain tissue
samples covering the entire possible transcript from exon 0a
in 5HDHD1a through to the end of the 30UTR of STS was also
sequenced with 13 overlapping sequencing reactions. This was to




1b and reverse primer of exon 2 were used for sequencing of the
upstream region of the STS gene (see Supplementary Table I for
sequences). Primer pairs (Supplementary Table II) were designed
and used to sequence the rest of the coding sequence and tran-
scribed 30UTR sequences present in the mRNA. Standard PCR
conditions were employed. All sequencing was performed com-
merciallyusinganAppliedBiosystems3730DNAsequencerbyThe
SequencingService,UniversityofDundee.Sequencewascompared
to genomic DNA NCBI ref sequence (NC_000023.10) using Co-
donCode Aligner version 3 (CodonCode Corporation) to deduce
transcribed regions in the brain transcripts.
mRNA Expression
The STS primers and probe sequences were acquired from
Applied Biosystems. The probe was FAM labeled and designed
based on sequences spanning across exons 4 and 5 of the gene
(Hs00996676_m1). Endogenous control gene assays used were
human GAPDH and b-Actin (Applied Biosystems). Quantitative
PCR was performed in triplicate for each sample on a Stratagene
MX5003Pusingastandardprotocol.Theexpressiondataproduced
wereanalyzedandconvertedintothresholdcyclevalues(Ctvalues)
using the software program MXPro Version 4.0 (Stratagene).
Statistical Analyses
For the association studies, TDT analysis for each sample was
carried out using the program software UNPHASED, which in-
cludessubjectswithmissingparentalgenotypes[Dudbridge,2008].
In the currentanalysis a ﬂag indicating the presence of an X-linked
gene was included, therefore only maternal transmissions were
counted.In addition, the UNPHASED program allows for permu-
tations of the data, which allows some correction for multiple
testing. Linkage disequilibrium across the SNPs and haplotype
analysis were performed in Haploview [Barrett et al., 2005].
For the mRNA expression studies, mean values were obtained
from the triplicate Ct values for each probe per sample. The target
STS mRNA expression was normalized to two endogenous refer-
ence genes (GAPDH and b-Actin) to generate a DCt value. The
relationship between the DCt values (STS mRNA expression)
and the different genotype groups were analyzed by t-test in the
analytical program SPSS Data Editor Version 17.0. In order to
analyze both housekeeping genes together, geNORM software
[Vandesompele et al., 2002] was used to create a gene expression
normalization factor which is calculated for each sample based on
the geometric mean of the housekeeping reference genes.
RESULTS
SNP Marker Association Study
Hardy–Weinberg equilibrium, calculated with allele frequencies
fromfemalesonly,wasobservedforallSNPs.Allelefrequenciesand
genotype frequencies were similar between the two sites. Results
are shown in Table I. Four tagging SNPs from the original study
[Brookesetal., 2008] werealso genotypedinthis extended sample:
rs5934740, rs7058445, rs2270112, and rs12861247. Of these,
rs2270112 and rs12861247, which were signiﬁcantly associated in
the original study, were found to maintain signiﬁcant association
with ADHD in the extended dataset with similar odds ratios as the
original study (rs2270112 OR was 1.48; rs12861247 was 2.05). Of
the eight SNPs not previously genotyped, ﬁve SNPs residing in the
ﬁrst two introns also demonstrated signiﬁcant association with
ADHD. In the ﬁrst intron of the STS gene three SNPs displayed
signiﬁcantassociationwithADHD:rs6639786(P¼0.01),rs5934769
(P¼0.02), rs5934770 (P¼0.02). Within intron 2, one SNP indi-
catedevidenceofanassociation,rs1733558(P¼0.01).Inaddition,
rs1473666inthe0balternativeexonalsoyieldedasigniﬁcantresult
(P¼0.05). All D0 linkage disequilibrium values are shown in
Figure 1 which demonstrates one haploype block with low recom-
bination. The application of the stringent multiple testing Bonfer-
roni correction resulted in none of the SNP markers preserving
statisticalsigniﬁcanceforassociation.Anoverallgene-widesigniﬁ-
canttestbypermutationanalysis(1,000permutations)suggesteda
weak trend towards signiﬁcance (P¼0.09).
Ofallpossiblehaplotypes,sevenhadatleasta1%frequency.There
was signiﬁcant over-transmission of one allele speciﬁc haplotype:
CGGTTCTGCTGG (haplotype frequency¼0.23, c
2¼10.13, P¼
BROOKES ET AL. 14190.02), which consisted of all the signiﬁcantly over-transmitted
alleles for individual SNPs. This did not survive Bonferroni cor-
rection for the seven allele speciﬁc haplotypes tested.
The analysis was re-run excluding female probands (N¼47)
to investigate the association in males. The markers rs12861247
(P¼0.02) and rs17335568 (P¼0.04) in intron 2 remained signiﬁ-
cantlyassociatedandLDpatternsacrosstheregionthatdidnotalter
substantially (see Supplementary Fig. 1 for LD plot of male only
sample). It might be expected that ADHD females would have
greater than expected homozygous rates for the signiﬁcant risk
alleles seen in hemizygous males. Therefore, the frequency of
homozygote females for the risk alleles that were associated in the
entire sample were compared to that estimated from the allele
frequencies provided by HapMap or dbSNP. The sample was
found to have a higher frequency of homozygous females for the
risk G-allele of the marker rs5934770 than expected from estima-
tions from dbSNP data (89% vs. 72%; P¼0.002). A trend for a
higher frequency of females homozygous for the risk G-allele of
rs12861247 (P¼0.06) was also observed. Neither of the SNPs
associatedwiththemaleonlyanalysishadsigniﬁcantlyhigherthan
expected risk allele homozygotes in the females.
Alternate First Exon Usage in Brain Transcript
Figures2and3demonstrateallalternativeﬁrstexonspresentinthe
cDNA with the negative control for mRNA (the ampliﬁcation of
intron2sequencewhichshouldonlybepresentingenomic)andthe
positive control for mRNA (the sequence spanning exons 3–5
which is too large to resolve from genomic) in Figure 2. Within
the brain STS transcript exons 0a, 1b, and 2 are the most abundant
TABLE I. Allele frequencies and TDT analysis result
SNP Location HWE Genotyped MAF
Informative
trios P-value T NT OR 95% CI
Over-transmitted
allele
rs1473666 Exon 0b 0.81 95.7 0.455 236 0.05 101 86 1.17 0.92–2.06 C
rs1000900 Intron 1 0.20 98.9 0.273 265 0.7 89 78 1.14 0.85–2.00 G
rs5934740 Intron1 0.78 91.5 0.461 211 0.33 87 81 1.07 0.75–1.77 G
rs6639786 Intron1 0.92 96.7 0.436 246 0.01 103 82 1.26 1.05–2.36 T
rs11095437 Intron1 0.05 99.1 0.233 266 0.36 85 69 1.23 0.97–2.36 T
rs2024159 Intron1 0.56 97.9 0.264 255 1 81 75 1.08 0.75–1.82 C
rs5934769 Intron1 0.13 86.9 0.423 224 0.03 83 69 1.20 0.92–2.26 T
rs5934770 Intron1 0.10 99.3 0.155 269 0.02 50 40 1.25 0.87–2.79 G
rs2270112 Intron 1 0.27 97.3 0.27 252 0.03 76 58 1.31 1.06–2.75 C
rs7058445 Intron 2 0.51 91.7 0.281 241 0.68 75 66 1.14 0.86–2.16 T
rs12861247 Intron 2 0.47 97.1 0.103 253 0.01 49 26 1.88 1.79–6.40 G
rs17335568 Intron 2 0.78 98.7 0.446 264 0.01 112 88 1.27 1.09–2.39 G
HWE, Hardy–Weinberg equilibrium; MAF, minor allele frequency; T, transmitted; NT, non-transmitted; OR, odds ratio; 95% CI, 95% conﬁdence intervals.
FIG. 1. D0 linkage disequilibrium between STS SNPs.
FIG. 2. PCR results for the presence in brain tissue of alternative
exons 0c, 1a, 1c, and 2.
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(exon1), 1c, 1d, and 1e. Exon 0d was too small to amplify
(17bp) but was not present in the DNA sequencing (see below).
DNA Sequencing
Sequencing of exon 0a, 1b, exon 2 in genomic DNA of 150 male
ADHD probands and 96 male controls revealed no new poly-
morphisms. Sequencing of the STS gene cDNA, created from RNA
isolatedfrom8ofthe21post-mortembrainsamplesconﬁrmedthe
inclusion of the alternative exons 0a and 1b [as described by Dalla
Valleetal.,2007]andexon 2inthetranscript(schematic inFig.4).
Nonewpolymorphismsweredetectedinthecodingsequenceorthe
UTRs present in the transcript. From exon 2 downstream, the
transcriptwasidenticaltoNCBIreferencesequence(NM_000351).
STS mRNA Expression
Gene expression of the STS gene in human post-mortem frontal
cortex samples was approximated by the measurement of mRNA
levelsviaquantitativePCR.Expressiondatainrelationtotheseven
SNP markersthat wereobservedto showstatisticalsigniﬁcance for





different Quantitative-PCR runs. A signiﬁcant relationship be-
tween the G-allele of rs12861247 and lower STS mRNA expression
relative to GAPDH was noted (t¼ 2.76, P¼0.01; Fig. 5). This
does not survive Bonferroni correction for the seven SNPs tested.
No associations with STS mRNA expression were evident for any
SNP when both housekeeping genes were analyzed together using
GeNORM (see Supplementary Fig. 2).
DISCUSSION
Inthisstudy,wehavedemonstratedfurtherevidenceforassociation
of the STS gene with ADHD. This study focussed on ﬁndings from
previous work [Brookes et al., 2008] by initially ﬁne mapping
a region spanning intron 1 and 2. Novel ﬁndings for ﬁve SNPs in
this region were found with signiﬁcant evidence for association:
rs6639786, rs5934769, rs5934770 located within intron 1;
rs17335568 located within intron 2; and rs1473666 in the alternate
exon(0b)locatedupstreaminthe50regionof5HD1A1A.Twoofthe
previously genotyped SNPs, rs2270112 and rs12861247 were also
still signiﬁcant in this larger sample. However, none survived
stringent correction for multiple testing and 1,000 permutations
of the data provided a trend for signiﬁcance only. Linkage disequi-
librium between the individual SNPs is very high with all the new
associations in this study being in high LD with the four SNPs
signiﬁcantlyassociatedinourpreviousstudy[Brookesetal.,2008].
FIG. 3. PCR results for the presence in brain tissue of alternative exons 0a, 0b, 1b, 1d, and 1e.
FIG. 4. Schematic diagrams showing alternate ﬁrst exons present in brain transcript mRNA in relation to genomic DNA.
BROOKES ET AL. 1421At this stage it is therefore difﬁcult to determine which SNP, or
SNPs are responsible for the signiﬁcant association, and which
appearsigniﬁcantbyvirtue ofLDwith other SNPs.Furtherstudies
todeterminewhichSNPshavefunctionaleffectsongeneexpression
andondownstreamtargetssuchasSTSactivityandDHEA/DHEA-S
levels may provide some indirect evidence for which SNP/s are
relevant.
Of the seven signiﬁcantly associated SNPs, risk alleles for four
(rs5934770, rs2270112, rs12861247, rs17335568) are predicted to
create new transcription factor binding sites (http://www.cbrc.jp/
research/db/TFSEARCH.html).Itiswellestablishedthattranscrip-
tional regulatory elements can be located within introns, particu-
larly intron 1 [e.g., Surinya et al., 1998; Gemel et al., 1999; Ozaki
etal.,2002].SeveralbindingsitesintheRel/NFKappatranscription
factor family are created by the risk allele for rs17335568 and a
upstream transcription factor 1 binding site for the risk allele of
rs5934770, a transcription factor involved in lipid and glucose
homeostasis, although it is not immediately apparent how these
particular bindingsitesmightbeinvolvedinADHDpathophysiol-
ogy. Of more interest is the POU3F1/Tst-1/Oct 6 binding site,
predictedtobeabolishedbytheriskalleleofrs12861247,whichmay
impactonmRNAexpression.POU3F1isamemberofthePOU-III
family of homeodomain proteins, whose primary role is thought
to be developmental. It is expressed in cells of the oligodendrocyte
lineage[Collarinietal.,1992;Wegner,2001]andFrantzetal.[1994]
suggested it also played a role in regulating transcription in differ-
entiated CNS neurons as well as in proliferating glial precursors.
Of particular interest is the ﬁnding that affected females, com-
pared to Hapmap or dbSNP allele frequencies were statistically
morelikelytobehomozygousfortheG-riskalleleofrs5934770and
showedatrendformorehomozygotesfortheG-alleleofrs12861247.
In our previous study [Brookes et al., 2008], we found statistically
morehomozygotefemalesfortheG-alleleofrs12861247andhypoth-
esizedamodelwherebyfemaleswouldneedtobehomozygoteforSTS
gene risk alleles in order to increase their susceptibility to ADHD.
These two SNPs located in intron 1 and 2, respectively have high
linkage disequilibrium between them (D0 ¼0.92) and may not be
independent ﬁndings. They may also be ‘‘tagging’’ another poly-
morphism,butifso,thisisunlikelytobeacommonpolymorphism
in exon 2 as sequencing in 150 ADHD male probands and nearly
100 controls did not reveal any new mutations. Therefore, further
investigationoftheassociationﬁndingswerefocussed upstream of
exon 2.
Tissue speciﬁcity of STS transcripts has been recently reported
[Dalla Valle et al., 2007; Zaichuk et al., 2007; Nardi et al., 2009],
although brain tissue speciﬁcity has not been widely investigated.
The presence or absence of each of the possible seven alternate
ﬁrst exons originally described by Dalla Valle et al. [2007] was
investigated by RT-PCR in human post-mortem brain tissueusing
individualprimerpairsforeachexonandconﬁrmedbysequencing
of the entire transcript. PCR products could be ampliﬁed in the
braintranscriptforexons0a,1b,and2.Thisisidenticaltooneofthe
two tissue speciﬁc transcript for adipose tissue identiﬁed by Dalla
Valle et al. [2006]. This transcript does not appear to contain exon
1a, otherwise known as exon 1, which is in the placental transcript.
Zaichuketal.[2007]demonstratedthattranscriptscontainingexon
1b were by far the most abundant in brain tissue (6,107amol/mg)
but they also detected minute amounts of exons 1a (7.6amol/mg)
and 1c (2.0amol/mg), but at such small levels of detection these
could arguably be as a result of measurement error. It is possible
that other exons are present in brain tissue but as RT-PCR will
favor ampliﬁcation of the most abundant transcript, the quantity
produced may not have been detectable by our methods.
Exon 1b is highly homologous to several non-human primate
STS mRNAs, suggesting a preserved functional role. It contains a
putative ATG start site, with a stronger Kozac consensus sequence
than the in frame ATG start site in exon 2. Use of the exon 1b
startsitewouldresultinatranscript12aminoacidslongerattheN-
terminal than that produced from the exon 2 start site, and seven
amino acids longer than that produced in placental tissue that
usestheexon1(exon1a)startsite.Signalpeptideprediction(http://
www.cbs.dtu.dk/services/SignalP/)suggeststhatthisdifferencehas
no impact on the signal peptidecleavage site. The presence of exon
0a upstream of exon 1b in the brain transcript is a novel ﬁnding in




signiﬁcantly associated marker, than a true functional variant, as
thisexondoesnotappeartobepresentinthebraintranscript,andis
not translated in tissue transcripts that do contain it [Dalla Valle
etal.,2006;Nardietal.,2009].Giventhepresenceofexon0aand1b
in the brain transcript, we also sequenced genomic DNA for these
exonsin150ADHDmaleprobandsandnearly100controlsbutdid
not discover any new polymorphisms.
Levels of STS mRNA were also investigated in human post-
mortem brain tissue in relation to genotype. We hypothesized that
because boys with STS deletions, and therefore no detectable STS
protein,havehigherthanexpectedratesofinattentiveADHD,some
boys with ADHD would be predicted to have lower levels of STS
mRNA. Although the G-allele of rs12861247, which was signiﬁ-
FIG. 5. Relative STS expression compared to GAPDH for
rs12861247. Higher values correspond to lower STS mRNA
levels. Error bars represent 95% CI.
1422 AMERICAN JOURNAL OF MEDICAL GENETICS PART BcantlyassociatedwithADHD,wasalsosigniﬁcantlyassociatedwith
alowerSTSmRNAlevelrelativetotheGAPDHcontrolgene,using
analternativemethodofanalysis,withmorethanonehousekeeping
gene control, did not support this initial ﬁnding. However, brain
tissue is composed of a variety of cell types such that mRNA
expression levels of genes may vary between samples as a result of
differencesincellcompositionoftheparticularpieceoftissueused.
These ﬁndings for STS mRNA expression levels in relation to
genotype in brain tissue therefore require further investigation,
preferably using a more cell speciﬁc approach such as laser capture
micro-dissection techniques. The use of post-mortem brain tissue
still has several advantages over in vitro techniques. The endoge-
nous promoters and all other gene sequences, etc. needed for gene
regulation are present in the tissue and this arguably provides a
morerelevantparadigmthancelllinesandreportervectorsystems,
which do not represent normal tissue. However, Additionally, the
tissueemployedforthisstudywasfrom‘‘normal’’individualswith
no known history of psychiatric disorder (although this cannot be
ruled out) and the sample size was small, and possibly limited in
powertodetectwhatarelikelytobesmalleffectsizesoftheseSNPs.
Additionally, the small sample size may not allow the detection of
rare brain transcripts that use exons 1a and 1c as suggested by
Zaichuk et al. [2007].
In summary, this association study provides further evidence
that genetic variation in the STS SNPs (rs1286124 gene may be
implicated inADHDsusceptibility. Oneof thesigniﬁcantly associ-
ated 7) in intron 2 may be associated with lower STS mRNA
expression as well as being more prevalent in female ADHD
homozygotes. Replication of these ﬁndings is needed as well as
further functional investigation of the associated alleles.
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